Related Experiment Videos
Chronological changes in the complement system in sepsis
1Critical Care and Emergency Center, Department of Bacteriology, Iwate Medical College, Iwate, Japan.
Insights
Serum complement levels, including C3a, C4a, C5a, CH50, C3, and C4, can indicate sepsis severity. Monitoring these complement components may help predict patient outcomes in sepsis.
Area of Science:
- Immunology
- Critical Care Medicine
- Biochemistry
Background:
- Sepsis is a life-threatening condition characterized by a dysregulated host response to infection.
- The complement system plays a crucial role in innate immunity and inflammation, and its activation is implicated in sepsis pathogenesis.
Purpose of the Study:
- To investigate the relationship between serum complement component levels and sepsis severity.
- To determine if complement levels can serve as prognostic markers for sepsis outcomes.
Main Methods:
- Measured serum levels of complement components (C3a, C4a, C5a, CH50, C3, C4, C5) in septic patients.
- Utilized radioimmunoassay, latex agglutination, nephelometry, and hemolysis assays for component measurement.
- Compared complement levels between surviving and nonsurviving patient groups over time.
Main Results:
- Nonsurviving patients exhibited significantly lower levels of CH50, C3, and C4 compared to survivors.
- Nonsurviving patients showed significantly higher levels of C3a and C4a than survivors.
- Initially elevated C5a levels in nonsurvivors, with no significant long-term intergroup differences.
Conclusions:
- Serum levels of C3a, C4a, C5a, CH50, C3, and C4 may act as indicators of sepsis severity.
- Monitoring the complement system could aid in predicting sepsis patient outcomes.
Abstract:
The time courses of serum complement levels and the severity of sepsis were compared in two groups of septic patients, one in which the patients survived (surviving group) and one in which they did not (nonsurviving group). The components of the complement system, namely, C3a, C4a, C5a, CH50, C3, C4, and C5, were measured at several points in time after the diagnosis of sepsis had been established. A 2-antibody radioimmunoassay was used to measure C3a, C4a, and C5a; the latex agglutination test was used to measure C3 and C4; nephelometry was used to measure C5; and Meyer's 50% hemolysis method was used to measure CH50. Following the diagnosis of sepsis, the levels of CH50, C3, and C4 were significantly lower in the nonsurviving than the surviving group, while the levels of C3a and C4a were significantly higher in the nonsurviving than the surviving group. The C5a levels were significantly higher in the nonsurviving than the surviving group, although no significant intergroup differences were subsequently noted. These results suggest that the serum levels of C3a, C4a, C5a, CH50, C3, and C4 could serve as indices of the severity of sepsis. Thus, monitoring the complement system may be useful for predicting the outcome of patients with sepsis.